DK1131052T3 - Vaginalt indgivelige progesteron-holdige tabletter og fremgangsmåde til fremstilling deraf - Google Patents

Vaginalt indgivelige progesteron-holdige tabletter og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1131052T3
DK1131052T3 DK99972096.4T DK99972096T DK1131052T3 DK 1131052 T3 DK1131052 T3 DK 1131052T3 DK 99972096 T DK99972096 T DK 99972096T DK 1131052 T3 DK1131052 T3 DK 1131052T3
Authority
DK
Denmark
Prior art keywords
vaginally
deliverable
progesterone
preparation
containing tablets
Prior art date
Application number
DK99972096.4T
Other languages
Danish (da)
English (en)
Inventor
Azariah Jossifoff
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK1131052T3 publication Critical patent/DK1131052T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99972096.4T 1998-11-18 1999-11-17 Vaginalt indgivelige progesteron-holdige tabletter og fremgangsmåde til fremstilling deraf DK1131052T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12712998A IL127129A (en) 1998-11-18 1998-11-18 Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
PCT/IL1999/000619 WO2000028970A1 (en) 1998-11-18 1999-11-17 Vaginally administrable progesterone-containing tablets and method for preparing same

Publications (1)

Publication Number Publication Date
DK1131052T3 true DK1131052T3 (da) 2012-10-15

Family

ID=11072154

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99972096.4T DK1131052T3 (da) 1998-11-18 1999-11-17 Vaginalt indgivelige progesteron-holdige tabletter og fremgangsmåde til fremstilling deraf

Country Status (8)

Country Link
US (4) US7300664B1 (enExample)
EP (2) EP1131052B1 (enExample)
JP (2) JP4667601B2 (enExample)
AU (1) AU1176200A (enExample)
DK (1) DK1131052T3 (enExample)
ES (1) ES2390959T3 (enExample)
IL (1) IL127129A (enExample)
WO (1) WO2000028970A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
FR2821555B1 (fr) * 2001-03-01 2003-05-16 Besins Int Lab Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
CA2510292A1 (en) * 2002-12-20 2004-07-15 Dynogen Pharmaceuticals, Inc. Methods of treating non-painful bladder disorders using .alpha.2.delta. subunit calcium channel modulators
KR100742001B1 (ko) * 2003-03-21 2007-07-23 다이노젠 파마세우티컬스, 인코포레이티드 평활근 모듈레이터 및 알파2 델타 서브유닛 칼슘 채널모듈레이터를 이용한 하부 요로 질환의 치료 방법
DE10316583A1 (de) * 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
WO2009070794A1 (en) * 2007-11-29 2009-06-04 Jackson Gregg A Progesterone-containing compositions and devices
US9107696B2 (en) 2008-08-06 2015-08-18 Emory University Method of embryo transfer that eliminates transferred air while hormonally inducing implantation and apparatus
WO2011073995A2 (en) 2009-12-14 2011-06-23 Lincoln Pharmaceuticals Limited Liquid vaginal spray of progesterone
FR2997627B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
CN114129530A (zh) * 2021-12-08 2022-03-04 南京康川济医药科技有限公司 一种黄体酮缓释组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121663A (en) 1956-02-09 1964-02-18 Plough Lab Inc Carbon dioxide releasing laxative suppository
US4252787A (en) * 1976-12-27 1981-02-24 Cambridge Research And Development Group Anti-fertility composition and method
US4310510A (en) * 1976-12-27 1982-01-12 Sherman Kenneth N Self administrable anti-fertility composition
US4187286A (en) * 1979-01-02 1980-02-05 G&W Laboratories, Inc. Contraceptive suppository
US4322399A (en) * 1979-10-19 1982-03-30 Ortho Pharmaceutical Corporation Vaginal suppository
JPS58152809A (ja) * 1982-03-05 1983-09-10 Eisai Co Ltd 安定な発泡性「膣」坐剤
US4583211A (en) * 1982-06-15 1986-04-15 Tokyo Shibaura Denki Kabushiki Kaisha Frequency detecting circuit for digital information reproducing system
JPS6165822A (ja) * 1984-09-06 1986-04-04 Kao Corp 月経困難症治療用膣投与剤
US5084277A (en) * 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) * 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
DK95093D0 (da) * 1993-08-20 1993-08-20 Novo Nordisk As Farmaceutisk formulering indeholdende et hormon
US5543150A (en) 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
CH689802A5 (de) * 1995-01-16 1999-11-30 Grapha Holding Ag Einrichtung zur Vereinzelung von stapelweise zugeführten flachen Gegenständen.
US5804277A (en) * 1995-11-30 1998-09-08 The United States Of America As Represented By The Secretary Of The Air Force Three-dimensional fiber weave with cubic symmetry and no zero valued shear moduli
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US5837861A (en) * 1997-02-10 1998-11-17 Inspire Pharmaceuticals, Inc. Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
US5993856A (en) 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6306914B1 (en) * 1997-10-21 2001-10-23 Columbia Laboratories, Inc. Progestin therapy for maintaining amenorrhea
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
FR2772617B1 (fr) 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US20070178139A1 (en) * 1998-11-18 2007-08-02 Yankov Vladimir I Vaginally administratable progesterone-containing tablets and method for preparing same
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
DE102012021570A1 (de) * 2012-11-02 2014-05-22 Merck Patent Gmbh Eu-aktivierte Leuchtstoffe

Also Published As

Publication number Publication date
EP1131052B1 (en) 2012-07-11
EP1131052A1 (en) 2001-09-12
US7300664B1 (en) 2007-11-27
JP2002529494A (ja) 2002-09-10
US20050181045A1 (en) 2005-08-18
US7320800B2 (en) 2008-01-22
IL127129A (en) 2004-06-01
WO2000028970A1 (en) 2000-05-25
EP1131052A4 (en) 2009-04-01
US20060188571A1 (en) 2006-08-24
IL127129A0 (en) 1999-09-22
AU1176200A (en) 2000-06-05
US7393543B2 (en) 2008-07-01
JP2011026335A (ja) 2011-02-10
EP2386291A1 (en) 2011-11-16
JP4667601B2 (ja) 2011-04-13
ES2390959T3 (es) 2012-11-20
US20050008694A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
DK1041879T3 (da) Desinfektionsmiddel og fremstillingsmetode
NO20002831D0 (no) Medikament i myk tablettform og fremgangsmÕter for fremstilling av dette
NO20032332L (no) Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
NO20031772D0 (no) Stenoprofilurmatriks og fremgangsmåte for fremstilling av slik
NO20015888L (no) Implanterbart gelpreparat og fremgangsmåter for fremstilling derav
IL135261A (en) Footwear and its method of construction
NO20030844L (no) Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav
DK1339292T3 (da) Sammensætning og fremgangsmåde
DK0734260T3 (da) Paroxetintabletter og fremgangsmåde til fremstilling deraf
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
DK1109625T3 (da) Pulverisator og fremgangsmåde til pulverisering
NO20014994D0 (no) Hvitt pulver og fremgangsmåte for fremstilling derav
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
NO20003555L (no) Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer
NO20040368L (no) Fremgangsmate til fremstilling og rensing av natriumhydrid
NO20024413L (no) FremgangsmÕte for tilvirkning og bruk av mikrogrupper av biologiske materialer
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
PL340487A1 (en) Macaroni and method of making same
DK1027047T3 (da) Eprosartan-arginyl-ladningsneutraliseringskompleks og fremgangsmåde til dets fremstilling og formulering
NO20033743D0 (no) Fremgangsmåte og fremstilling citalopram
DK1046719T3 (da) D-galactosesammensætning og fremgangsmåde til fremstilling deraf